MicroRNAs Derived from Extracellular Vesicles: Keys to Understanding SARS-CoV-2 Vaccination Response in Cancer Patients?

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provoked a global pandemic identified as coronavirus disease (COVID-19), with millions of deaths worldwide. However, several important questions regarding its impact on public health remain unanswered, such as the impact of vaccination on vulnerable subpopulations such as cancer patients. Cytokine storm and a sustained inflammatory state are commonly associated with immune cell depletion, being manifested in most immunocompromised individuals. This strong immunosuppression can lead to a dysfunctional antiviral response to natural viral infection and compromised vaccination response. Extracellular vesicles (EVs) are membrane-bound vesicles released from cells that are involved in intercellular communication. EVs carry various molecules including microRNAs that play a crucial role in COVID-19 pathophysiology, influencing cellular responses. This review summarizes the state of the art concerning the role of EV-derived miRNAs in COVID-19 infection and their potential use as prognosis biomarkers for vaccination response in cancer patients.

[1]  R. Gambari,et al.  The Cystic Fibrosis Transmembrane Conductance Regulator Gene (CFTR) Is under Post-Transcriptional Control of microRNAs: Analysis of the Effects of agomiRNAs Mimicking miR-145-5p, miR-101-3p, and miR-335-5p , 2023, Non-Coding RNA.

[2]  E. Cione,et al.  SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections , 2023, Clinical chemistry and laboratory medicine.

[3]  M. Verdonck,et al.  An mRNA mix redirects dendritic cells towards an antiviral program, inducing anticancer cytotoxic stem cell and central memory CD8+ T cells , 2023, Frontiers in Immunology.

[4]  R. Duarte,et al.  Evaluating Data Sharing of SARS-CoV-2 Genomes for Molecular Epidemiology across the COVID-19 Pandemic , 2023, Viruses.

[5]  M. Rehm,et al.  Extensive blood transcriptome analysis reveals cellular signaling networks activated by circulating glycocalyx components reflecting vascular injury in COVID-19 , 2023, Frontiers in Immunology.

[6]  J. Bukh,et al.  SARS‐CoV‐2 spike mRNA vaccine sequences circulate in blood up to 28 days after COVID‐19 vaccination , 2023, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[7]  Rong Huang,et al.  HMGB3 Targeted by miR-145-5p Impacts Proliferation, Migration, Invasion, and Apoptosis of Breast Cancer Cells , 2022, Computational and mathematical methods in medicine.

[8]  M. Halim,et al.  A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sites , 2022, Immunobiology.

[9]  T. Wu,et al.  COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection , 2022, Journal of Biomedical Science.

[10]  J. Pawlotsky,et al.  Proviral role of human respiratory epithelial cell‐derived small extracellular vesicles in SARS‐CoV‐2 infection , 2022, Journal of extracellular vesicles.

[11]  F. Amati,et al.  Expression analysis of miRNA hsa‐let7b‐5p in naso‐oropharyngeal swabs of COVID‐19 patients supports its role in regulating ACE2 and DPP4 receptors , 2022, Journal of cellular and molecular medicine.

[12]  L. Thorpe,et al.  ACE2-containing defensosomes serve as decoys to inhibit SARS-CoV-2 infection , 2022, PLoS biology.

[13]  M. Saadh,et al.  Efficacy of COVID-19 vaccines , 2022, Microbial Pathogenesis.

[14]  H. Sousa,et al.  MicroRNAs as Potential Tools for Predicting Cancer Patients’ Susceptibility to SARS-CoV-2 Infection and Vaccination Response , 2022, Cells.

[15]  G. Paolisso,et al.  Exosomal miR-145 and miR-885 Regulate Thrombosis in COVID-19 , 2022, The Journal of Pharmacology and Experimental Therapeutics.

[16]  A. Sette,et al.  Humoral and cellular immune memory to four COVID-19 vaccines , 2022, Cell.

[17]  Rongkui Zhang,et al.  Extracellular vesicle biomarkers for pancreatic cancer diagnosis: a systematic review and meta-analysis , 2022, BMC cancer.

[18]  F. Baldanti,et al.  Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant , 2022, Nature Communications.

[19]  Vanathi Gopalakrishnan,et al.  Realistic biomarkers from plasma extracellular vesicles for detection of beryllium exposure , 2022, International Archives of Occupational and Environmental Health.

[20]  T. Ahn,et al.  Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer. , 2022, Cancer letters.

[21]  J. Garcia-Aymerich,et al.  Higher mortality and intubation rate in COVID-19 patients treated with noninvasive ventilation compared with high-flow oxygen or CPAP , 2022, Scientific Reports.

[22]  M. Dimopoulos,et al.  Plasma Metabolomic Alterations Induced by COVID-19 Vaccination Reveal Putative Biomarkers Reflecting the Immune Response , 2022, Cells.

[23]  N. Seidah,et al.  Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity , 2022, Journal of virology.

[24]  Jingping Liu,et al.  Peritoneal M2 macrophage-derived extracellular vesicles as natural multitarget nanotherapeutics to attenuate cytokine storms after severe infections , 2022, bioRxiv.

[25]  B. Walker,et al.  Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection , 2022, eLife.

[26]  R. Gottardo,et al.  Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients , 2022, JAMA oncology.

[27]  Feng Zhang,et al.  miR-145-5p Inhibits Neuroendocrine Differentiation and Tumor Growth by Regulating the SOX11/MYCN Axis in Prostate cancer , 2022, Frontiers in Genetics.

[28]  M. Emoto,et al.  New-onset Type 1 Diabetes after COVID-19 mRNA Vaccination , 2022, Internal medicine.

[29]  N. Blanca-López,et al.  Plasma miRNA profile at COVID-19 onset predicts severity status and mortality , 2022, Emerging microbes & infections.

[30]  S. Zeger,et al.  Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression , 2022, The Lancet.

[31]  T. Hope,et al.  Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2 , 2022, Nature communications.

[32]  Nan Wang,et al.  Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron , 2022, Cell.

[33]  Xinxiang Li,et al.  Highly‐metastatic colorectal cancer cell released miR‐181a‐5p‐rich extracellular vesicles promote liver metastasis by activating hepatic stellate cells and remodelling the tumour microenvironment , 2022, Journal of extracellular vesicles.

[34]  Mark M. Davis,et al.  Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination , 2022, Cell.

[35]  K. Khunti,et al.  Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection , 2021, Nature Medicine.

[36]  M. Pfaffl,et al.  Extracellular Vesicle Associated miRNAs Regulate Signaling Pathways Involved in COVID-19 Pneumonia and the Progression to Severe Acute Respiratory Corona Virus-2 Syndrome , 2021, Frontiers in Immunology.

[37]  Y. Shyr,et al.  COVID-19 vaccination and breakthrough infections in patients with cancer , 2021, Annals of Oncology.

[38]  Dylan T Burnette,et al.  Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets , 2021, Nature Cell Biology.

[39]  Dipendra Gyawali,et al.  A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems , 2021, Nature Communications.

[40]  H. Brüssow.  mRNA vaccines against COVID‐19: a showcase for the importance of microbial biotechnology , 2021, Microbial biotechnology.

[41]  J. Casado,et al.  BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity , 2021, Vaccine.

[42]  Michael J. Hogan,et al.  mRNA Vaccines in the COVID-19 Pandemic and Beyond. , 2021, Annual review of medicine.

[43]  T. Fleming,et al.  Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer–BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines , 2021, The Journal of Immunology.

[44]  Aaron M. Rosenfeld,et al.  mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern , 2021, Science.

[45]  Benjamin Kye Jyn Tan,et al.  Efficacy of COVID-19 vaccines in immunocompromised patients: A systematic review and meta-analysis , 2021, medRxiv.

[46]  J. Vidal-Alaball,et al.  Spike-based COVID-19 immunization increases antibodies to nucleocapsid antigen , 2021, Translational Research.

[47]  B. LaFleur,et al.  Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors , 2021, Nature Medicine.

[48]  F. Cognetti,et al.  Immunogenicity and Safety of COVID-19 Vaccine BNT162b2 for Patients with Solid Cancer: A Large Cohort Prospective Study from a Single Institution , 2021, Clinical Cancer Research.

[49]  D. Tieleman,et al.  Supramolecular Organization of SARS-CoV and SARS-CoV-2 Virions Revealed by Coarse-Grained Models of Intact Virus Envelopes , 2021, bioRxiv.

[50]  Jisook Moon,et al.  Potential Therapeutic Effect of Micrornas in Extracellular Vesicles from Mesenchymal Stem Cells against SARS-CoV-2 , 2021, Cells.

[51]  Chen-Yu Zhang,et al.  Decreased inhibition of exosomal miRNAs on SARS-CoV-2 replication underlies poor outcomes in elderly people and diabetic patients , 2021, Signal Transduction and Targeted Therapy.

[52]  Sagar,et al.  Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine , 2021, Nature.

[53]  F. Perez,et al.  Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9 , 2021, Nature Communications.

[54]  Yazan Batineh,et al.  Safety of COVID‐19 vaccines , 2021, Journal of medical virology.

[55]  S. Cauchemez,et al.  Impact of BNT162b2 Vaccination and Isolation on SARS-CoV-2 Transmission in Israeli Households: An Observational Study , 2021, medRxiv.

[56]  S. Sureshchandra,et al.  Single-cell profiling of T and B cell repertoires following SARS-CoV-2 mRNA vaccine , 2021, bioRxiv.

[57]  A. Sarmento,et al.  Serological response to a single dose of a SARS-CoV-2 mRNA vaccine , 2021, Journal of Virological Methods.

[58]  Zhe-Sheng Chen,et al.  Features of Cytokine Storm Identified by Distinguishing Clinical Manifestations in COVID-19 , 2021, Frontiers in Public Health.

[59]  Kimberly J. Hassett,et al.  Impact of lipid nanoparticle size on mRNA vaccine immunogenicity. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[60]  T. Pan,et al.  The interferon-stimulated exosomal hACE2 potently inhibits SARS-CoV-2 replication through competitively blocking the virus entry , 2021, Signal Transduction and Targeted Therapy.

[61]  Xingyi Ge,et al.  The taxonomy, host range and pathogenicity of coronaviruses and other viruses in the Nidovirales order , 2021, Animal Diseases.

[62]  A. Lenzi,et al.  Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID‐19 mRNA vaccine , 2021, Diabetes/metabolism research and reviews.

[63]  Shuo Wang,et al.  microRNA-145-5p Inhibits Migration, Invasion, and Metastasis in Hepatocellular Carcinoma by Inhibiting ARF6 , 2021, Cancer management and research.

[64]  A. Banerjea,et al.  SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia , 2021, Frontiers in Immunology.

[65]  P. Rodari,et al.  Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection , 2021, Viruses.

[66]  Sangkyu Park,et al.  MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein , 2021, Theranostics.

[67]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[68]  Suzana Borschiver,et al.  Analysis of the COVID-19 Vaccine Development Process: an Exploratory Study of Accelerating Factors and Innovative Environments , 2021, Journal of pharmaceutical innovation.

[69]  D. Centonze,et al.  The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis , 2021, Cells.

[70]  T. Welte,et al.  Circulating cardiovascular microRNAs in critically ill COVID‐19 patients , 2021, European journal of heart failure.

[71]  M. R. Chacón,et al.  Liquid Biopsy-Based Exo-oncomiRNAs Can Predict Prostate Cancer Aggressiveness , 2021, Cancers.

[72]  G. Milano,et al.  COVID-19 vaccine race: watch your step for cancer patients , 2020, British Journal of Cancer.

[73]  L. Martin-Jaular,et al.  Extracellular vesicles containing ACE2 efficiently prevent infection by SARS‐CoV‐2 Spike protein‐containing virus , 2020, Journal of extracellular vesicles.

[74]  D. Weissman,et al.  SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation , 2020, Immunity.

[75]  Jianquan Hou,et al.  MiR-24-3p as a prognostic indicator for multiple cancers: from a meta-analysis view , 2020, Bioscience reports.

[76]  T. Korcsmáros,et al.  SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients , 2020, Frontiers in Immunology.

[77]  I. Osuna‐Ramírez,et al.  Underexpression of circulating miR-145-5p and miR-133a-3p are associated with breast cancer and immunohistochemical markers , 2020, Journal of Cancer Research and Therapeutics.

[78]  Xi Chen,et al.  miR-24-3p promotes colon cancer progression by targeting ING1 , 2020, Signal Transduction and Targeted Therapy.

[79]  Ralf Bartenschlager,et al.  Structures and distributions of SARS-CoV-2 spike proteins on intact virions , 2020, Nature.

[80]  Shuwen Liu,et al.  Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19 , 2020, Acta Pharmacologica Sinica.

[81]  Xia Zhong,et al.  A Thermostable mRNA Vaccine against COVID-19 , 2020, Cell.

[82]  Ralf Bartenschlager,et al.  SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography , 2020, Nature Communications.

[83]  Yizhou Dong,et al.  Formulation and Delivery Technologies for mRNA Vaccines. , 2020, Current topics in microbiology and immunology.

[84]  David A. Drew,et al.  Cancer and Risk of COVID‐19 Through a General Community Survey , 2020, medRxiv.

[85]  A. Hutcheon,et al.  Extracellular Vesicles Secreted by Corneal Epithelial Cells Promote Myofibroblast Differentiation , 2020, Cells.

[86]  B. Giepmans,et al.  Endocytosis of Extracellular Vesicles and Release of Their Cargo from Endosomes , 2020, ACS nano.

[87]  K. Yuen,et al.  Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2 , 2020, Cell.

[88]  Young-Jun Park,et al.  Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.

[89]  E. Holmes,et al.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.

[90]  Kimberly J. Hassett,et al.  Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines , 2019, Molecular therapy. Nucleic acids.

[91]  M. Jiang,et al.  miR-145-5p inhibits the proliferation and migration of bladder cancer cells by targeting TAGLN2 , 2018, Oncology letters.

[92]  Alireza Khodadadi-Jamayran,et al.  Prognostic role of elevated mir-24-3p in breast cancer and its association with the metastatic process , 2018, Oncotarget.

[93]  Y. Liu,et al.  miR‐24‐3p promotes cell migration and proliferation in lung cancer by targeting SOX7 , 2018, Journal of cellular biochemistry.

[94]  Graça Raposo,et al.  Shedding light on the cell biology of extracellular vesicles , 2018, Nature Reviews Molecular Cell Biology.

[95]  E. Solary,et al.  Gap junction-mediated transfer of miR-145-5p from microvascular endothelial cells to colon cancer cells inhibits angiogenesis , 2016, Oncotarget.

[96]  Qingyuan Zhang,et al.  miRNA-24-3p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting p27Kip1. , 2015, Oncology reports.

[97]  T. Schlake,et al.  Developing mRNA-vaccine technologies , 2012, RNA biology.

[98]  Frank D Sistare,et al.  Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. , 2009, Clinical chemistry.

[99]  OUP accepted manuscript , 2022, Journal of Molecular Cell Biology.

[100]  Ping Li,et al.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020 .